TrialMalaria journal2011

A phase I trial to evaluate the safety and pharmacokinetics of low-dose methotrexate as an anti-malarial drug in Kenyan adult healthy volunteers.

Roma Chilengi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.